REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Regent Pacific Group Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services | Management of Companies and Enterprises
Full name: Regent Pacific Group Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Regent Pacific Group Limited is mainly engaged in exploration and mining of coal and other natural resources through its subsidiaries in Yunnan province of China and Western Australia. The company was founded in 1991.

Headquarters
8th Floor, Henley Building, 5 Queen＇s Road Central, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Regent Pacific Group Limited report to view the information.

Website: http://www.endurancerp.com

Basic Information
Total Employees:
Purchase the Regent Pacific Group Limited report to view the information.
Outstanding Shares:
Purchase the Regent Pacific Group Limited report to view the information.
Registered Capital:
Purchase the Regent Pacific Group Limited report to view the information.
Financial Auditors:
Purchase the Regent Pacific Group Limited report to view the information.
Incorporation Date:
May 07, 1991
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
56.56%
Subsidiaries
Amerinvest Coal Industry Holding Company Limited
100%
Deep Longevity Limited
100%
Deep Longevity, Inc (Cayman Islands)
100%
Company Performance
Financial values in the chart are available after Regent Pacific Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
50%▲
Total operating revenue
-32.98%▼
Operating profit (EBIT)
84.75%▲
EBITDA
12.76%▲
Net Profit (Loss) for the Period
78.51%▲
Total assets
-95.34%▼
Total equity
N/A
Operating Profit Margin (ROS)
16183.74%▲
Net Profit Margin
12745.94%▲
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-1.62%▼
Cash Ratio
-1.45%▼

Similar companies

Simcere Pharmaceutical Group Limited (Nanjing) (先声药业集团有限公司 (南京))
 
Grand Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
CSPC Pharmaceutical Group Limited
 
Sino Biopharmaceutical Limited
China Traditional Chinese Medicine Holdings Co. Limited
 
United Laboratories International Holdings Limited
Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港))
 
Regencell Bioscience Holdings Ltd.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo